{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:30Z","timestamp":1707524310113},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.7759\/cureus.17647","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:29:10Z","timestamp":1630517350000},"source":"Crossref","is-referenced-by-count":1,"title":["Persistent Raynaud's Phenomenon Following Methylphenidate Hydrochloride Use During the COVID-19 Pandemic"],"prefix":"10.7759","author":[{"given":"Christopher","family":"Laboe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Batchelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Vasireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04745-5","article-title":"Raynaud's phenomenon-an update on diagnosis, classification and management","volume":"38","author":"Pauling JD","year":"2019","unstructured":"Pauling JD, Hughes M, Pope JE. Raynaud's phenomenon-an update on diagnosis, classification and management. Clin Rheumatol. 2019, 38:3317-30. 10.1007\/s10067-019-04745-5","journal-title":"Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1526-2_3","article-title":"Epidemiology of Raynaud\u2019s phenomenon","author":"Maundrell A","year":"2015","unstructured":"Maundrell A, Proudman SM. Epidemiology of Raynaud\u2019s phenomenon. Raynaud\u2019s Phenomenon. Wigley FM, Herrick AL, Flavahan NA (ed): Springer, New York, NY; 2015. 21-35. 10.1007\/978-1-4939-1526-2_3"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102439","article-title":"Systemic sclerosis induced by CNS stimulants for ADHD: a case series and review of the literature","volume":"19","author":"Meridor K","year":"2020","unstructured":"Meridor K, Levy Y. Systemic sclerosis induced by CNS stimulants for ADHD: a case series and review of the literature. Autoimmun Rev. 2020, 19:102439. 10.1016\/j.autrev.2019.102439","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686699","article-title":"Case report: systemic sclerosis after Covid-19 infection","volume":"12","author":"Fineschi S","year":"2021","unstructured":"Fineschi S. Case report: systemic sclerosis after Covid-19 infection. Front Immunol. 2021, 12:686699. 10.3389\/fimmu.2021.686699","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.20l02828","article-title":"Posttraumatic stress disorder exacerbation as a result of public masking in times of COVID-19","volume":"22","author":"Jolly TS","year":"2020","unstructured":"Jolly TS, Pandian GS, Batchelder E, Jain A. Posttraumatic stress disorder exacerbation as a result of public masking in times of COVID-19. Prim Care Companion CNS Disord. 2020, 22:20l02828. 10.4088\/PCC.20l02828","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.20l02877","article-title":"COVID-19 and obsessive-compulsive disorder: the nightmare just got real","volume":"23","author":"Jain A","year":"2021","unstructured":"Jain A, Bodicherla KP, Bashir A, Batchelder E, Jolly TS. COVID-19 and obsessive-compulsive disorder: the nightmare just got real. Prim Care Companion CNS Disord. 2021, 23:20l02877. 10.4088\/PCC.20l02877","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud's phenomenon","volume":"375","author":"Wigley FM","year":"2016","unstructured":"Wigley FM, Flavahan NA. Raynaud's phenomenon. N Engl J Med. 2016, 375:556-65. 10.1056\/NEJMra1507638","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxx207","article-title":"Blood pressure in children with attention deficit\/hyperactivity disorder","volume":"23","author":"Grisaru S","year":"2018","unstructured":"Grisaru S, Yue M, Samuel SM, Chaput KH, Hamiwka LA. Blood pressure in children with attention deficit\/hyperactivity disorder. Paediatr Child Health. 2018, 23:e102-8. 10.1093\/pch\/pxx207","journal-title":"Paediatr Child Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181639aaa","article-title":"Methylphenidate and dextroamphetamine-induced peripheral vasculopathy","volume":"14","author":"Syed RH","year":"2008","unstructured":"Syed RH, Moore TL. Methylphenidate and dextroamphetamine-induced peripheral vasculopathy. J Clin Rheumatol. 2008, 14:30-3. 10.1097\/RHU.0b013e3181639aaa","journal-title":"J Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0033","article-title":"OROS-methylphenidate-induced Raynaud's phenomenon: a dose-related side effect","volume":"25","author":"Bayram \u00d6","year":"2015","unstructured":"Bayram \u00d6, Herg\u00fcner S. OROS-methylphenidate-induced Raynaud's phenomenon: a dose-related side effect. J Child Adolesc Psychopharmacol. 2015, 25:521-2. 10.1089\/cap.2015.0033","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.23301","article-title":"Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients","volume":"58","author":"Goldman W","year":"2008","unstructured":"Goldman W, Seltzer R, Reuman P. Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients. Arthritis Rheum. 2008, 58:563-6. 10.1002\/art.23301","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11752","article-title":"COVID-19-induced vestibular neuritis, hemi-facial spasms and Raynaud's phenomenon: a case report","volume":"12","author":"Vanaparthy R","year":"2020","unstructured":"Vanaparthy R, Malayala SV, Balla M. COVID-19-induced vestibular neuritis, hemi-facial spasms and Raynaud's phenomenon: a case report. Cureus. 2020, 12:e11752. 10.7759\/cureus.11752","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.20l02763","article-title":"Mental health crisis secondary to COVID-19-related stress: a case series from a child and adolescent inpatient unit","volume":"22","author":"Jolly TS","year":"2020","unstructured":"Jolly TS, Batchelder E, Baweja R. Mental health crisis secondary to COVID-19-related stress: a case series from a child and adolescent inpatient unit. Prim Care Companion CNS Disord. 2020, 22:20l02763. 10.4088\/PCC.20l02763","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1191\/1358863x05vm639ra","article-title":"Mechanisms of Raynaud's disease","volume":"10","author":"Cooke JP","year":"2005","unstructured":"Cooke JP, Marshall JM. Mechanisms of Raynaud's disease. Vasc Med. 2005, 10:293-307. 10.1191\/1358863x05vm639ra","journal-title":"Vasc Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001260","article-title":"Lisdexamfetamine-associated tonsure trichotillomania (Epub ahead of print)","author":"Jolly T","year":"2020","unstructured":"Jolly T, Waxmonsky J, Baweja R. Lisdexamfetamine-associated tonsure trichotillomania (Epub ahead of print). J Clin Psychopharmacol. 2020, 10.1097\/JCP.0000000000001260","journal-title":"J Clin Psychopharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11083","article-title":"Bupropion-induced severe leukocytosis","volume":"12","author":"Jolly TS","year":"2020","unstructured":"Jolly TS, Singh J, Baweja R. Bupropion-induced severe leukocytosis. Cureus. 2020, 12:e11083. 10.7759\/cureus.11083","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12912","article-title":"Drug-induced Raynaud's phenomenon: beyond \u03b2-adrenoceptor blockers","volume":"82","author":"Khouri C","year":"2016","unstructured":"Khouri C, Blaise S, Carpentier P, Villier C, Cracowski JL, Roustit M. Drug-induced Raynaud's phenomenon: beyond \u03b2-adrenoceptor blockers. Br J Clin Pharmacol. 2016, 82:6-16. 10.1111\/bcp.12912","journal-title":"Br J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-051507","article-title":"COVID-19 and adolescent depression and suicide risk screening outcomes (Epub ahead of print)","author":"Mayne SL","year":"2021","unstructured":"Mayne SL, Hannan C, Davis M, et al.. COVID-19 and adolescent depression and suicide risk screening outcomes (Epub ahead of print). Pediatrics. 2021, 10.1542\/peds.2021-051507","journal-title":"Pediatrics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30110-3","article-title":"ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group","volume":"4","author":"Cortese S","year":"2020","unstructured":"Cortese S, Asherson P, Sonuga-Barke E, et al.. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. Lancet Child Adolesc Health. 2020, 4:412-4. 10.1016\/S2352-4642(20)30110-3","journal-title":"Lancet Child Adolesc Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2020.05.009","article-title":"Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19","volume":"59","author":"Loades ME","year":"2020","unstructured":"Loades ME, Chatburn E, Higson-Sweeney N, et al.. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020, 59:1218-39. 10.1016\/j.jaac.2020.05.009","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/69323-persistent-raynauds-phenomenon-following-methylphenidate-hydrochloride-use-during-the-covid-19-pandemic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:45Z","timestamp":1707506925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/69323-persistent-raynauds-phenomenon-following-methylphenidate-hydrochloride-use-during-the-covid-19-pandemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.17647","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}